» Articles » PMID: 26629317

Cyclin A2: At the Crossroads of Cell Cycle and Cell Invasion

Overview
Specialty Biochemistry
Date 2015 Dec 3
PMID 26629317
Citations 34
Authors
Affiliations
Soon will be listed here.
Abstract

Cyclin A2 is an essential regulator of the cell division cycle through the activation of kinases that participate to the regulation of S phase as well as the mitotic entry. However, whereas its degradation by the proteasome in mid mitosis was thought to be essential for mitosis to proceed, recent observations show that a small fraction of cyclin A2 persists beyond metaphase and is degraded by autophagy. Its implication in the control of cytoskeletal dynamics and cell movement has unveiled its role in the modulation of RhoA activity. Since this GTPase is involved in both cell rounding early in mitosis and later, in the formation of the cleavage furrow, this suggests that cyclin A2 is a novel actor in cytokinesis. Taken together, these data point to this cyclin as a potential mediator of cell-niche interactions whose dysregulation could be taken as a hallmark of metastasis.

Citing Articles

A comprehensive apoptotic assessment of niloticin in cervical cancer cells: a tirucallane-type triterpenoid from (Wall.) Parker.

Joseph A, Biji M, Murali V, Sherin D, Valsan A, Sukumaran V RSC Med Chem. 2024; .

PMID: 39246746 PMC: 11378019. DOI: 10.1039/d4md00318g.


A new method for network bioinformatics identifies novel drug targets for mucinous ovarian carcinoma.

Craig O, Lee S, Pilcher C, Saoud R, Abdirahman S, Salazar C NAR Genom Bioinform. 2024; 6(3):lqae096.

PMID: 39184376 PMC: 11344246. DOI: 10.1093/nargab/lqae096.


Ensiled diet improved the growth performance of Tibetan sheep by regulating the rumen microbial community and rumen epithelial morphology.

Zhao J, Zhao X, Gao J, Bai B, Niu J, Yang Y J Anim Sci. 2024; 102.

PMID: 38902909 PMC: 11245705. DOI: 10.1093/jas/skae173.


Hypermethylation of the Gene Body in Is Involved in Breast Cancer Cell Proliferation and Is a Potential Blood-Based Biomarker for Early Detection and a Poor Prognosis.

Shen H, Hung C, Davis C, Su C, Liao L, Shih H Biomolecules. 2024; 14(5).

PMID: 38785978 PMC: 11118508. DOI: 10.3390/biom14050571.


CCNA2 and NEK2 regulate glioblastoma progression by targeting the cell cycle.

Zhou H, Wang Y, Wang T, Wu W, Cao Y, Zhang B Oncol Lett. 2024; 27(5):206.

PMID: 38516683 PMC: 10956385. DOI: 10.3892/ol.2024.14339.


References
1.
Bendris N, Loukil A, Cheung C, Arsic N, Rebouissou C, Hipskind R . Cyclin A2: a genuine cell cycle regulator?. Biomol Concepts. 2014; 3(6):535-43. DOI: 10.1515/bmc-2012-0027. View

2.
Loukil A, Zonca M, Rebouissou C, Baldin V, Coux O, Biard-Piechaczyk M . High-resolution live-cell imaging reveals novel cyclin A2 degradation foci involving autophagy. J Cell Sci. 2014; 127(Pt 10):2145-50. DOI: 10.1242/jcs.139188. View

3.
Birkenfeld J, Nalbant P, Bohl B, Pertz O, Hahn K, Bokoch G . GEF-H1 modulates localized RhoA activation during cytokinesis under the control of mitotic kinases. Dev Cell. 2007; 12(5):699-712. PMC: 1965589. DOI: 10.1016/j.devcel.2007.03.014. View

4.
Ombrato L, Malanchi I . The EMT universe: space between cancer cell dissemination and metastasis initiation. Crit Rev Oncog. 2014; 19(5):349-61. DOI: 10.1615/critrevoncog.2014011802. View

5.
Bourdon D, Wing M, Edwards E, Sondek J, Harden T . Quantification of isozyme-specific activation of phospholipase C-beta2 by Rac GTPases and phospholipase C-epsilon by Rho GTPases in an intact cell assay system. Methods Enzymol. 2006; 406:489-99. DOI: 10.1016/S0076-6879(06)06037-X. View